TAZICEF (Hospira, Inc.)


Welcome to the PulseAid listing for the TAZICEF drug offered from Hospira, Inc.. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: CEFTAZIDIME
SUBSTANCE NAME: CEFTAZIDIME
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1986-03-06
END MARKETING DATE: 0000-00-00


TAZICEF HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTAZICEF from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 1986-03-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-5082_35aa59d8-4e5e-470d-8ec2-6cc3e35bbf43
PRODUCT NDC: 0409-5082
APPLICATION NUMBER: ANDA062662

Other CEFTAZIDIME Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Ceftazidime and Dextrose
Hospira, Inc.TAZICEF
Sagent PharmaceuticalsCeftazidime
Sandoz IncCeftazidime
WG Critical Care, LLCCeftazidime